https://www.marketscreener.com/quote/stock/YUMANITY-THERAPEUTICS-117003859/news/Yumanity-Therapeutics-Dosed-First-Patient-in-Phase-1-2-Clinical-Study-of-VISTA-Targeting-KVA12123-43824333/?utm_source=telegram&utm_medium=social&utm_campaign=share